169 related articles for article (PubMed ID: 9650444)
1. Molecular interaction between factor VII and tissue factor.
Higashi S; Iwanaga S
Int J Hematol; 1998 Apr; 67(3):229-41. PubMed ID: 9650444
[TBL] [Abstract][Full Text] [Related]
2. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
3. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
Doñate F; Kelly CR; Ruf W; Edgington TS
Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793
[TBL] [Abstract][Full Text] [Related]
4. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
Dickinson CD; Shobe J; Ruf W
J Mol Biol; 1998 Apr; 277(4):959-71. PubMed ID: 9545384
[TBL] [Abstract][Full Text] [Related]
5. Identification of regions of bovine factor VII essential for binding to tissue factor.
Higashi S; Nishimura H; Aita K; Iwanaga S
J Biol Chem; 1994 Jul; 269(29):18891-8. PubMed ID: 8034645
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity.
Higashi S; Matsumoto N; Iwanaga S
J Biol Chem; 1996 Oct; 271(43):26569-74. PubMed ID: 8900128
[TBL] [Abstract][Full Text] [Related]
7. The factor VII zymogen structure reveals reregistration of beta strands during activation.
Eigenbrot C; Kirchhofer D; Dennis MS; Santell L; Lazarus RA; Stamos J; Ultsch MH
Structure; 2001 Jul; 9(7):627-36. PubMed ID: 11470437
[TBL] [Abstract][Full Text] [Related]
8. Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation.
Dittmar S; Ruf W; Edgington TS
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):787-93. PubMed ID: 9032467
[TBL] [Abstract][Full Text] [Related]
9. Active site modification of factor VIIa affects interactions of the protease domain with tissue factor.
Dickinson CD; Ruf W
J Biol Chem; 1997 Aug; 272(32):19875-9. PubMed ID: 9242651
[TBL] [Abstract][Full Text] [Related]
10. High affinity Ca(2+)-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activity.
Sabharwal AK; Birktoft JJ; Gorka J; Wildgoose P; Petersen LC; Bajaj SP
J Biol Chem; 1995 Jun; 270(26):15523-30. PubMed ID: 7797546
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
Rao LV; Ruf W
Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
[TBL] [Abstract][Full Text] [Related]
12. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
Jin J; Perera L; Stafford D; Pedersen L
J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements for the interaction between tissue factor and factor VII: characterization of chymotrypsin-derived tissue factor polypeptides.
O'Brien DP; Anderson JS; Martin DM; Byfield PG; Tuddenham EG
Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):7-12. PubMed ID: 8503864
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor pathway.
McVey JH
Baillieres Clin Haematol; 1994 Sep; 7(3):469-84. PubMed ID: 7841596
[TBL] [Abstract][Full Text] [Related]
15. Two sites in the tissue factor extracellular domain mediate the recognition of the ligand factor VIIa.
Ruf W; Edgington TS
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8430-4. PubMed ID: 1924302
[TBL] [Abstract][Full Text] [Related]
16. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
Edgington TS; Mackman N; Fan ST; Ruf W
Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S15-27. PubMed ID: 1364116
[TBL] [Abstract][Full Text] [Related]
17. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa.
Dickinson CD; Kelly CR; Ruf W
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14379-84. PubMed ID: 8962059
[TBL] [Abstract][Full Text] [Related]
18. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
19. Factor VII mutant V154G models a zymogen-like form of factor VIIa.
Toso R; Bernardi F; Tidd T; Pinotti M; Camire RM; Marchetti G; High KA; Pollak ES
Biochem J; 2003 Feb; 369(Pt 3):563-71. PubMed ID: 12358603
[TBL] [Abstract][Full Text] [Related]
20. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
Zhang E; St Charles R; Tulinsky A
J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
